Stifel Nicolaus analyst Jonathan Block maintained a Buy rating on Sonendo (SONX – Research Report) yesterday and set a price target of $1.00. The company’s shares closed yesterday at $0.27.
According to TipRanks, Block is a 5-star analyst with an average return of 8.4% and a 52.38% success rate. Block covers the Healthcare sector, focusing on stocks such as Idexx Laboratories, Align Tech, and Henry Schein.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Sonendo with a $1.19 average price target, representing a 339.11% upside. In a report released on October 26, Bank of America Securities also reiterated a Buy rating on the stock with a $1.00 price target.
See the top stocks recommended by analysts >>
The company has a one-year high of $2.95 and a one-year low of $0.21. Currently, Sonendo has an average volume of 266K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Sonendo (SONX) Company Description:
Sonendo Inc is a commercial-stage medical technology company focused on saving teeth from tooth decay, the most prevalent chronic disease globally.
Read More on SONX:
